ALPS Advisors’s Exact Sciences EXAS Stock Holding History

ALPS Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,076	Closed	-$322K	–	897
2018 Q3	$322K	Buy	+4,076	New	+$266K	﹤0.01%	893
2018 Q1	–	Sell	-3,998	Closed	-$210K	–	915
2017 Q4	$210K	Buy	+3,998	New	+$213K	﹤0.01%	811

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

ALPS Advisors's EXAS Position: Q4 2018 in Review

ALPS Advisors sold out of Exact Sciences (EXAS) in Q4 2018, closing a stake of 4,076 shares — an estimated $322K sold.

ALPS Advisors first reported a position in EXAS in Q4 2017 and held it in 2 quarters. The position peaked at $322K in Q3 2018. 369 funds tracked by Wall St. Rank hold EXAS as of Q4 2018.

ALPS Advisors reported no remaining Exact Sciences position as of Q4 2018 after selling out during the quarter.
ALPS Advisors sold 4,076 Exact Sciences shares in Q4 2018, an estimated $322K.
ALPS Advisors first reported a position in Exact Sciences in Q4 2017 and held it in 2 quarters.
ALPS Advisors's Exact Sciences position peaked at $322K in Q3 2018.
369 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2018.

Based on ALPS Advisors's 13F filing for Q4 2018, filed 4 Feb 2019.